pmc logo image
Logo of envhperEHP WebsiteAbout EHPPublicationsNews By TopicAuthorsSubscribePressEmail AlertsSearch EHP

Formats:

Environ Health Perspect. 1990 August; 88: 269–276.
PMCID: PMC1567992
Research Article
Historical developments and perspectives in inorganic fiber toxicity in man.
I J Selikoff
Mount Sinai School of Medicine, City University of New York, NY 10029.
Abstract
The first patient known to have died from asbestosis (1900) began work in 1885, approximately 5 years after the industrial use of asbestos began in Britain. Mineral particles were found in his lungs. No special comment was made of their fibrous nature then nor when the first case was reported in 1924. The various neoplasms attributed to asbestos in the next decades posed an additional question: What influence did the fibrous shape of the particles have on carcinogenic potential? The cogency of the problem was amplified by the identification in humans of asbestos-like neoplasms with a fiber other than asbestos (erionite) and by the production of such neoplasms in experimental animals with a variety of man-made inorganic fibers, often used as substitutes for asbestos. The lessons learned about asbestos may help guide us in evaluating current fiber problems.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Gross P, Cralley LJ, DeTreville RT. "Asbestos" bodies: their nonspecificity. Am Ind Hyg Assoc J. 1967 Nov–Dec;28(6):541–542. [PubMed]
  • WEISS A. Pleurakrebs bei Lungenasbestose, in vivo morphologisch gesichert. Medizinische. 1953 Jan 17;6(3):93–94. [PubMed]
  • KOENIG J. [On asbestosis.]. Arch Gewerbepathol Gewerbehyg. 1960;18:159–204. [PubMed]
  • WAGNER JC, SLEGGS CA, MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. [PubMed]
  • Newhouse ML, Thompson H. Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med. 1965 Oct;22(4):261–269. [PubMed]
  • SELIKOFF IJ, CHURG J, HAMMOND EC. ASBESTOS EXPOSURE AND NEOPLASIA. JAMA. 1964 Apr 6;188:22–26. [PubMed]
  • Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972 Mar;48(3):797–821. [PubMed]
  • Harington JS. Fiber carcinogenesis: epidemiologic observations and the Stanton hypothesis. J Natl Cancer Inst. 1981 Nov;67(5):977–989. [PubMed]
  • Bignon J, Jaurand MC. Réaction du poumon profond à l'inhalation de fibres minérales. C R Seances Soc Biol Fil. 1980;174(4):479–487. [PubMed]
  • Jaurand MC, Bastie-Sigeac I, Renier A, Bignon J. Comparative toxicities of different forms of asbestos on rat pleural mesothelial cells. Environ Health Perspect. 1983 Sep;51:153–158. [PubMed]
  • Wagner JC, Pooley FD, Berry G, Seal RM, Munday DE, Morgan J, Clark NJ. A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg. 1982;26(1-4):423–431. [PubMed]
  • Churg A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest. 1988 Mar;93(3):621–628. [PubMed]
  • Gylseth B, Churg A, Davis JM, Johnson N, Morgan A, Mowe G, Rogers A, Roggli V. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial. Scand J Work Environ Health. 1985 Apr;11(2):107–110. [PubMed]
  • Warnock ML, Wolery G. Asbestos bodies or fibers and the diagnosis of asbestosis. Environ Res. 1987 Oct;44(1):29–44. [PubMed]
  • Pooley FD, Ranson DL. Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy. J Clin Pathol. 1986 Mar;39(3):313–317. [PubMed]
  • McDonald JC. Tremolite, other amphiboles, and mesothelioma. Am J Ind Med. 1988;14(2):247–249. [PubMed]
  • Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ. 1980;(30):237–246. [PubMed]
  • Viallat JR, Raybuad F, Passarel M, Boutin C. Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch Environ Health. 1986 Sep–Oct;41(5):282–286. [PubMed]
  • Tuomi T, Segerberg-Konttinen M, Tammilehto L, Tossavainen A, Vanhala E. Mineral fiber concentration in lung tissue of mesothelioma patients in Finland. Am J Ind Med. 1989;16(3):247–254. [PubMed]
  • DOLL R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955 Apr;12(2):81–86. [PubMed]
  • Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943--1976. Ann N Y Acad Sci. 1979;330:91–116. [PubMed]
  • Oliver LC, Eisen EA, Greene RE, Sprince NL. Asbestos-related disease in railroad workers. A cross-sectional study. Am Rev Respir Dis. 1985 Apr;131(4):499–504. [PubMed]
  • Mancuso TF. Mesothelioma among machinists in railroad and other industries. Am J Ind Med. 1983;4(4):501–513. [PubMed]
  • Mancuso TF. Relative risk of mesothelioma among railroad machinists exposed to chrysotile. Am J Ind Med. 1988;13(6):639–657. [PubMed]
  • Nicholson WJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality--1980-2030. Am J Ind Med. 1982;3(3):259–311. [PubMed]
  • Nicholson WJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality--1980-2030. Am J Ind Med. 1982;3(3):259–311. [PubMed]
  • Baker EL, Dagg T, Greene RE. Respiratory illness in the construction trades. I. The significance of asbestos-associated pleural disease among sheet metal workers. J Occup Med. 1985 Jul;27(7):483–489. [PubMed]
  • Oliver LC, Eisen EA, Greene R, Sprince NL. Asbestos-related pleural plaques and lung function. Am J Ind Med. 1988;14(6):649–656. [PubMed]
  • Rosenstock L, Hudson LD. The pleural manifestations of asbestos exposure. Occup Med. 1987 Apr–Jun;2(2):383–407. [PubMed]
  • Selikoff IJ, Hammond EC, Churg J. Asbestos exposure, smoking, and neoplasia. JAMA. 1968 Apr 8;204(2):106–112. [PubMed]
  • Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci. 1979;330:473–490. [PubMed]
  • WYSS V. Presenza di aghi di amianto nelle urine di operai esposti al rischio asbestosico. Rass Med Ind Ig Lav. 1953 Jan–Feb;22(1):55–56. [PubMed]
  • Kotin P, Paul W. Results of a lung cancer detection program in an asbestos industry. Recent Results Cancer Res. 1982;82:131–137. [PubMed]
  • Roboz J, Chahinian AP, Holland JF, Silides D, Szrajer L. Early diagnosis and monitoring of transplanted human malignant mesothelioma by serum hyaluronic acid. J Natl Cancer Inst. 1989 Jun 21;81(12):924–928. [PubMed]
  • Friedmann T. Progress toward human gene therapy. Science. 1989 Jun 16;244(4910):1275–1281. [PubMed]